Dec. 27, 2023
IRVINE, CALIFORNIA — Acclarent, Inc., part of Johnson & Johnson MedTech and a leader in minimally invasive ear, nose and throat (ENT) technologies, has received clearance from the U.S. Food and Drug Administration (FDA) for use of its Acclarent AERA® Eustachian Tube Balloon Dilation System to treat children ages 8-17 with persistent obstructive Eustachian tube dysfunction (OETD). This clearance expands